Semaglutide the original ~14.9% average body-weight reduction at 52 weeks Targets GLP-1 (one pathway) Weekly injection Best for: first-timers, or anyone sensitive to side effects Tirzepatide the upgrade ~22.1% average body-weight reduction at 52 weeks Targets GLP-1 + GIP (two pathways) Weekly injection Best for: plateaued on semaglutide, or want stronger results Retatrutide the newest ~25.9% average body-weight reduction at 52 weeks Targets GLP-1 + GIP + glucagon (three pathways) Weekly injection Best for: want the newest science, comfortable with a compounded option Semaglutide: the original Semaglutide is a GLP-1 receptor agonist
B12 can be given, orally, or through intramuscular injections
Wonderslim Pea Protein Chips Available in Hickory BBQ, Salt & Vinegar, and Ranch flavors, each bag of kosher, gluten-free chips provides: 10g complete pea protein 10g net carbs 6
The clinical performance of injectable GLP-1 agents is well-established and documented in extensive trial databases that have accumulated over a decade of commercial experience
BPC-157 peptide therapy injections reach the bloodstream fastest, but the form that is right for you might depend on your presenting clinical issue